Changeflow GovPing Healthcare & Life Sciences Pancreatic Resection in Fit Octogenarians With ...
Routine Notice Added Final

Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic Cancer

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

The NIH registered an observational clinical study (NCT07542782) examining survival outcomes of pancreatic cancer surgery and post-operative chemotherapy in patients aged 80 and older without metastatic disease, using data from a German cancer registry. The study compares patients who underwent surgical tumor resection with curative intent against those who did not, and further examines the role of additional treatment after surgery.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This is a clinical trial registry entry (NCT07542782) filed with ClinicalTrials.gov by the NIH, registering an observational study on pancreatic cancer treatment outcomes in fit octogenarians. The study will analyze data from a German cancer registry to compare survival between patients who undergo surgical resection versus no surgery, and between those who receive post-operative chemotherapy versus those who do not.

This registry entry is informational and does not create compliance obligations. Healthcare providers, clinical investigators, and patients interested in pancreatic cancer surgical outcomes in elderly populations may reference this study for awareness of ongoing research.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Pancreatic Resection in Fit Octogenarians With Nonmetastatic Pancreatic Cancer

Observational NCT07542782 Kind: OBSERVATIONAL Apr 21, 2026

Abstract

This study looks at how different treatment approaches affect survival in older people with pancreatic cancer that has not spread to other parts of the body. In particular, it focuses on patients aged 80 years and older who are still in relatively good general health and able to carry out normal daily activities.

Pancreatic cancer is a serious disease, and surgery to remove the tumor is often the only treatment that offers a chance of longer survival. However, older patients are less likely to receive surgery, even if they are otherwise fit. Doctors may hesitate to recommend surgery mainly because of the patient's age, rather than their overall health condition. This study aims to better understand whether surgery can still be beneficial for these older patients.

The study also examines the role of additional treatment after surgery, such as chemotherapy. In real-world medical practice, not all patients receive this follow-up treatment, especially older individuals who may have a slower recovery after surgery. This can make it difficult to understand whether such treatments truly improve survival.

To answer these questions, the study uses data from a large cancer registry in Germany. It compares patients who had surgery with those who did not, and it also looks at patients who received additional treatment after surgery versus those who did not. Special methods are used to take into account that some patients may not have been able to receive further treatment because t...

Conditions: Pancreatic Cancer

Interventions: All types of surgical tumor resection procedures with curative intent, No surgical resection

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Clinical investigators Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Cancer research Surgical outcomes
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!